Adenosine A3 receptor antagonists as anti‐tumor treatment in human prostate cancer: an in vitro study

Prostate cancer (PCa) is one of the most common cancers in men, and for patients with PCa that cannot be surgically resected or treated, androgen suppression therapy often results in significant adverse effects. Recent studies have shown that A3 adenosine receptors (A3ARs) are overexpressed in prost...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Maria Beatrice Morelli, Andrea Spinaci, Cui Chang, Rosaria Volpini, Catia Lambertucci, Matteo Landriscina, Vincenza Conteduca, Consuelo Amantini, Cristina Aguzzi, Laura Zeppa, Martina Giangrossi, Laura Soverchia, Matteo Santoni, Massimo Nabissi, Giorgio Santoni, Carlo Polidori
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2025-07-01
Serija:	FEBS Open Bio
Teme:	adenosine adenosine receptor antagonists chemotherapy PC3 cell line prostate cancer
Online dostop:	https://doi.org/10.1002/2211-5463.70024
Oznake:	Označite Brez oznak, prvi označite!